Skip to main content
. 2020 Mar 6;13:491–502. doi: 10.2147/JPR.S240911

Table 2.

Analysis of Change from Baseline in VAS Pain Intensity (Severe Pain Subgroup, ITT Population)

Endpoint Time Point (min) Mean Change from Baseline (95% Confidence Interval)a Estimated Treatment Effect (95% Confidence Interval) p-value
Methoxyflurane Standard Analgesic Treatment
Primary Endpoint 3 −4.69 (−7.27, −2.11) −0.96 (−3.68, 1.76) −3.73 (−7.48, 0.02) 0.051
5 −14.89 (−18.80, −10.99) −6.26 (−10.38, −2.13) −8.64 (−14.32, −2.96) 0.003b
10 −21.87 (−26.93, −16.81) −17.62 (−22.96, −12.28) −4.25 (−11.61, 3.11) 0.254
Overall −13.82 (−17.22, −10.42) −8.28 (−11.87, −4.69) −5.54 (−10.48, −0.59) 0.029b
Secondary Endpoint 15 −27.25 (22.23) −26.81 (17.92) −0.44 (−8.86, 7.98) 0.917
20 −33.43 (22.49) −31.45 (20.05) −1.98 (−11.04, 7.08) 0.665
25 −38.41 (23.34) −38.85 (19.16) 0.44 (−8.73, 9.61) 0.924
30 −43.96 (23.42) −43.88 (18.96) −0.08 (−9.23, 9.08) 0.986

Notes: Based on estimated marginal means. aMean change from baseline (standard deviation) is presented for 15, 20, 25 and 30 min time points. bMean difference significant at the 0.05 level (Bonferroni adjustment for multiple comparisons).

Abbreviations: ITT, intention-to-treat; VAS, visual analog scale.